Strategic partnerships Company has a history of collaboration, including a notable partnership with NCSDDC to distribute syphilis tests, suggesting openness to distribution and channel partnerships that could be expanded with diagnostic networks and public health programs.

Innovation recognition Recent innovation award from Johns Hopkins Centers for Innovative Diagnostics highlights a focus on advanced test development, making Diagnostics Direct a candidate for early adoption programs, pilot opportunities, and co-development ventures.

Clinical reach Specializes in CLIA Waived STD diagnostics that are easy to administer and read, positioning the company to partner with primary care clinics, urgent care, community health centers, and telehealth platforms needing rapid, on-site testing.

Growth potential Revenue range indicates a small-to-mid market footprint with room for scale; targeting distribution partners, reference labs, and regional health systems could accelerate volume and geographic expansion.

Tech-enabled sales Digital presence and modern tech stack (WordPress, analytics, marketing automation) facilitate targeted outreach, onboarding campaigns, and self-serve partner programs to drive sales efficiency.